Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 3 x FEC 3 x DOC / Gemcitabine|DRUG: 3 x FEC 3 x DOC
Sponsor: Ludwig-Maximilians - University of Munich